Rit activators encompass a diverse range of chemical compounds that indirectly augment the functional activity of Rit through various signaling pathways, each playing a distinct role in modulating cellular processes that converge on Rit. Forskolin, for instance, enhances Rit's activity by raising intracellular cAMP levels, subsequently activating PKA. This activation leads to a phosphorylation cascade that indirectly activates Rit, modifying the interaction and functionality of its associated proteins. Similarly, PMA, through PKC activation, and Epigallocatechin gallate, as a kinase inhibitor, contribute to this enhancement by altering the phosphorylation landscape in which Rit operates, reducing competitive signaling or influencing kinase activity favorably for Rit's function. LY294002 and Wortmannin, both PI3K inhibitors, indirectly promote Rit's role by downregulating Akt signaling, a pathway that often competes with or overshadows Rit's signaling mechanisms. This reduced PI3K/Akt pathway activity allows alternative pathways, where Rit might play a significant role, to become more prominent.
Further contributing to the activation of Rit are compounds like Sphingosine-1-phosphate and Thapsigargin, which modulate lipid and calcium signaling, respectively. These modifications influence the cellular microenvironment and signaling equilibrium, favoring Rit's activation. Genistein's tyrosine kinase inhibition capacity reduces competition from tyrosine kinase signaling, allowing Rit pathways to be more active. Similarly, U0126 and SB203580, by inhibiting MEK1/2 and p38 MAPK, respectively, shift the signaling balance towards Rit-associated pathways. A23187, by elevating intracellular calcium levels, activates calcium-dependent signaling crucial for Rit's function. Staurosporine, despite being a broad-spectrum kinase inhibitor, selectively facilitates Rit activation by lifting the inhibition on specific kinases linked to Rit's pathways. Collectively, these Rit activators, through their targeted effects on cellular signaling, enhance the functional activity of Rit in a coordinated and multi-faceted manner.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin enhances Rit's activity by increasing intracellular cAMP levels, which activate PKA. PKA then phosphorylates substrates that indirectly activate Rit through modification of its interacting proteins or signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, leading to the phosphorylation of proteins that interact with Rit. This phosphorylation indirectly enhances Rit's activity by altering its signaling context. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This compound acts as a kinase inhibitor, potentially reducing competitive signaling pathways, which indirectly enhances Rit's functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that indirectly enhances Rit activity. By inhibiting PI3K, it reduces downstream Akt signaling, potentially allowing alternative pathways involving Rit to become more prominent. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
It modulates lipid signaling, potentially enhancing Rit's activity by influencing the lipid environment of cellular membranes where Rit operates. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
This compound increases intracellular calcium levels, indirectly enhancing Rit activity by activating calcium-dependent signaling pathways that Rit may be involved in. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, Genistein indirectly enhances Rit's activity by reducing competition from tyrosine kinase signaling, which could otherwise overshadow Rit's signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAPK inhibitor could enhance Rit's functional activity by shifting the signaling balance towards Rit-associated pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
By increasing intracellular calcium levels, A23187 indirectly enhances Rit's activity through the activation of calcium-dependent signaling pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
As a broad-spectrum protein kinase inhibitor, Staurosporine might lead to the selective activation of Rit pathways by reducing the inhibition exerted by specific kinases. | ||||||